West Pharmaceutical Services Inc (WST)
338.12
-5.88
(-1.71%)
USD |
NYSE |
Nov 14, 16:00
332.71
-5.41
(-1.60%)
Pre-Market: 07:38
West Pharmaceutical Services Net Income (TTM): 499.60M for Sept. 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 499.60M |
| June 30, 2024 | 524.90M |
| March 31, 2024 | 568.70M |
| December 31, 2023 | 593.40M |
| September 30, 2023 | 559.40M |
| June 30, 2023 | 518.70M |
| March 31, 2023 | 552.10M |
| December 31, 2022 | 585.90M |
| September 30, 2022 | 630.60M |
| June 30, 2022 | 685.60M |
| March 31, 2022 | 684.40M |
| December 31, 2021 | 661.80M |
| September 30, 2021 | 612.50M |
| June 30, 2021 | 519.20M |
| March 31, 2021 | 423.10M |
| December 31, 2020 | 346.20M |
| September 30, 2020 | 311.70M |
| June 30, 2020 | 285.70M |
| March 31, 2020 | 260.60M |
| December 31, 2019 | 241.70M |
| September 30, 2019 | 229.80M |
| June 30, 2019 | 228.70M |
| March 31, 2019 | 218.70M |
| December 31, 2018 | 206.90M |
| September 30, 2018 | 154.90M |
| Date | Value |
|---|---|
| June 30, 2018 | 150.70M |
| March 31, 2018 | 133.40M |
| December 31, 2017 | 150.70M |
| September 30, 2017 | 189.80M |
| June 30, 2017 | 176.40M |
| March 31, 2017 | 182.30M |
| December 31, 2016 | 143.50M |
| September 30, 2016 | 137.80M |
| June 30, 2016 | 101.70M |
| March 31, 2016 | 84.80M |
| December 31, 2015 | 95.60M |
| September 30, 2015 | 93.60M |
| June 30, 2015 | 123.10M |
| March 31, 2015 | 132.90M |
| December 31, 2014 | 127.10M |
| September 30, 2014 | 119.30M |
| June 30, 2014 | 115.10M |
| March 31, 2014 | 107.70M |
| December 31, 2013 | 112.30M |
| September 30, 2013 | 109.80M |
| June 30, 2013 | 97.80M |
| March 31, 2013 | 83.20M |
| December 31, 2012 | 80.70M |
| September 30, 2012 | 78.40M |
| June 30, 2012 | 80.50M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
241.70M
Minimum
Dec 2019
685.60M
Maximum
Jun 2022
503.29M
Average
538.50M
Median
Net Income (TTM) Benchmarks
| Repligen Corp | -1.901M |
| Perspective Therapeutics Inc | -59.02M |
| Retractable Technologies Inc | -17.87M |
| Xtant Medical Holdings Inc | -3.333M |
| Catheter Precision Inc | -9.491M |